Rates and predictors of recurrent work disability due to common mental health disorders in the United States.

by Fraser W Gaspar, Catherine S Zaidel, Carolyn S Dewa
Published 2018-01-01

Examining the Factors Associated with Paid Employment of Clients Enrolled in First Episode of Psychosis Programs

by Carolyn S. Dewa, Lucy Trojanowski, Chiachen Cheng, Desmond Loong
Published 2012-01-01

Evidence for the effectiveness of police-based pre-booking diversion programs in decriminalizing mental illness: A systematic literature review.

by Carolyn S Dewa, Desmond Loong, Austin Trujillo, Sarah Bonato
Published 2018-01-01

Clinician experiences assessing work disability related to mental disorders.

by Carolyn S Dewa, Hiske Hees, Lucy Trojanowski, Aart H Schene
Published 2015-01-01

The influence of antidepressant and psychotherapy treatment adherence on future work leaves for patients with major depressive disorder

by Fraser W. Gaspar, Kerri Wizner, Joshua Morrison, Carolyn S. Dewa
Published 2020-06-01

The relationship between resident burnout and safety-related and acceptability-related quality of healthcare: a systematic literature review

by Carolyn S. Dewa, Desmond Loong, Sarah Bonato, Lucy Trojanowski, Margaret Rea
Published 2017-11-01

What Could Influence Workers' Decisions to Disclose a Mental Illness at Work?

by Carolyn S Dewa, Jaap Van Weeghel, Margot CW Joosen, Evelien PM Brouwers
Published 2020-07-01

Introducing plant biology graduate students to a culture of mental well‐being

by Carolyn S. Dewa, Karen Nieuwenhuijsen, Kathy J. Holmes‐Sullivan, Alexis K. Singh, Georgia Drakakaki
Published 2020-04-01

Advice about Work-Related Issues to Peers and Employers from Head and Neck Cancer Survivors.

by Carolyn S Dewa, Lucy Trojanowski, Sietske J Tamminga, Jolie Ringash, Maurene McQuestion, Jeffrey S Hoch
Published 2016-01-01

Workers' Decisions to Disclose a Mental Health Issue to Managers and the Consequences

by Carolyn S. Dewa, Jaap van Weeghel, Margot C. W. Joosen, Petra C. Gronholm, Evelien P. M. Brouwers
Published 2021-03-01

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

by Jeffrey S. Hoch, Annette Hay, Wanrudee Isaranuwatchai, Kednapa Thavorn, Natasha B. Leighl, Dongsheng Tu, Logan Trenaman, Carolyn S. Dewa, Chris O’Callaghan, Joseph Pater, Derek Jonker, Bingshu E. Chen, Nicole Mittmann
Published 2019-06-01